by Corinne Gangloff
October 9, 2019
Cleveland, OH, October 9, 2019 — US healthcare expenditures are forecast to advance 5.2% annually in nominal terms through 2023, according to Healthcare: United States, a report recently released by Freedonia Focus Reports. In real (inflation-adjusted) terms, spending is projected to rise 2.5% annually to 2023. Providers of healthcare services and products are expected to benefit from continued growth in consumer incomes and a projected rise in the number of acute and chronic conditions, itself driven by the graying of the US population. Faster gains in value terms will be limited by efforts to curb growth in healthcare costs.
Hospital services are projected to remain the largest expenditure segment. The continued aging of the population and the resulting growth in the number of acute and chronic conditions will continue to drive demand. Spending for home healthcare services is projected to exhibit the most rapid growth among discrete expenditure segments, with expected annual increases of 6.6% through 2023. The lower costs associated with home healthcare services relative to nursing homes and the desire of many persons to remain in their homes are expected to drive advances.
These and other key insights are featured in Healthcare: United States. This report forecasts to 2023 US healthcare expenditures in nominal and real (inflation-adjusted) US dollars. Total nominal expenditures are segmented by type in terms of:
Total nominal expenditures are also segmented by funding source as follows:
To illustrate historical trends, total healthcare expenditures in nominal and real terms; the various segments in nominal terms; and firm, establishment, employment, and payroll data are provided in annual series from 2008 to 2018.
More information about the report is available at:
Provide the following details to subscribe.